Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis

European Journal of Ophthalmology

Volumn 19, Issue 1, 2009, Pages 1-9

  Szaflik, Jerzy ^a,b   Szaflik, Jacek P ^a,b,c   Kamińskai, Anna ^a,b   Rowiński, Mariusz ^c   Kołodziejczyk, Wojciech ^c   Bełzecka Majszyk, Agata ^c   Gajda, Sebastian ^c   Izdebska, Justyna ^c  

^a Laser Eye Microsurgery Centre   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c NONE

Author keywords

Bacterial conjunctivitis; Cravit; Fluoroquinolone; Levofloxacin; Oftaquix; Quixin

Indexed keywords

EYE DROPS; LEVOFLOXACIN; OFTAQUIX; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BIOMICROSCOPY; BLOOD PRESSURE; BODY TEMPERATURE; BULBAR PARALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EYE DISCHARGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; CONJUNCTIVITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649358607     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900101     Document Type: Article

References (12)

1. Sheikh A, Hurwitz B, Cave J. Antibiotics for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2000; 2: CD001211.
2. Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB, Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group. A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Br J Ophthalmol 2003; 8: 1004-9.
3. Everitt HA, Little PS, Smith PW. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice [erratum 2006; 333: 468e]. BMJ 2006; 333: 321.
4. Cochereau I, Meddeb-Ouertani A, Khairallah M, et al. 3-day treatment with azithromycin 1.5% eye-drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children. Br J Ophthalmol 2007; 91: 465-9.
5. Kernt K, Martinez MA, Bertin D, et al. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. Eur J Ophthalmol 2005; 15: 541-9.
6. Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT, Levofloxacin Bacterial Conjunctivitis Active Control Study Group. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Ophthalmology 2003; 3: 457-65.
7. Lichtenstein SJ, Rinehart M, Levofloxacin Bacterial Conjunctivitis Study Group. Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients. J AAPOS 2003; 7: 317-24.
8. Raizman MB, Rubin JM, Graves AL, Rinehart M. Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers [erratum in 2004; 10: 1700; dosage error in text]. Clin Ther 2002; 9: 1439-50.
9. Colin J, Simonpoli S, Geldsetzer K, Ropo A. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol Scand 2003; 6: 611-3.
10. Koch HR, Kulus SC, Roessler M, Ropo A, Geldsetzer K. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops. J Cataract Refract Surg 2005; 7: 1377-85.
11. Bucci FA Jr. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am J Ophthalmol 2004; 2: 308-12.
12. Cagle G, Davis S, Rosenthal A, Smith J. Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study. Curr Eye Res 1981-1982; 9: 523-34.